Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 171

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 171
---
 in connection with the Business Combination and in connection with other matters could result in a significant amount of adverse press coverage and other adverse public statements affecting IWAC and Btab. Adverse press coverage and other negative publicity, whether or not driven by political or public sentiment, may also result in investigations by regulators, legislators

<div align='center'>67</div>

TABLE OF CONTENTS

and law enforcement officials or ultimately in legal claims. Responding to these investigations and lawsuits, regardless of the ultimate outcome of the proceeding, can divert the time and effort of senior management from the management of IWAC’s and Btab’s respective businesses.

Addressing any adverse publicity, governmental scrutiny, or enforcement or other legal proceedings is time consuming and expensive and, regardless of the factual basis for the assertions being made, could have a negative impact on the reputation of IWAC and Btab, on the morale and performance of their employees, and on their relationships with regulators. It may also have an adverse impact on their ability to take timely advantage of various business and market opportunities. The direct and indirect effects of negative publicity, and the demands of responding to and addressing it, may have a material adverse effect on IWAC’s and Btab’s respective businesses, financial condition, and results of operations.

The Business Combination Agreement and Stockholder Support Agreements contain provisions that may discourage other companies from attempting to acquire Btab for greater merger consideration.

The Business Combination Agreement and Stockholder Support Agreements contain provisions that may discourage a third party from submitting a business combination proposal to Btab that might result in greater value to Btab stockholders than the Business Combination with IWAC or may result in a potential competing acquirer proposing to pay a lower per share price to acquire Btab than it might otherwise have proposed to pay absent such provisions. These provisions include a general prohibition on Btab from soliciting, or, subject to certain exceptions, entering into discussions with any third party regarding any acquisition proposal or offers for competing transactions, and a commitment by certain Btab stockholders to vote in favor of the transactions contemplated by the Business Combination Agreement.

During the pendency of the Business Combination, IWAC will not be able to solicit, initiate or take any action to facilitate or encourage any inquiries or the making, submission or announcement of, or enter into a business combination with another party because of restrictions in the Business Combination Agreement.

During the pendency of the Business Combination, IWAC may not be able to enter into a business combination with another party because of non-solicitation provisions in the Business